Skip to main content
Caplight Logo









Cellbyte

Cellbyte

Private
MunichHealthcare & Life Scienceshttps://www.cellbyte.com/

Last Round

Seed

Nov 18, 2025

Total Funding Raised

$3.25M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cellbyte is a pharmaceutical technology company that provides an AI-driven platform to automate pricing, market access, and regulatory workflows for drug launches.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Vertical SaaS, Workflow Automation, Business Intelligence, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service

AI Layer

Application

Keywords

pricing and market accessP&MApharma analyticsvertical SaaSdocument intelligencehealth technology assessmentHTAdrug launch softwareAI copilotworkflow automationpharma commercializationRAGretrieval-augmented generationpharma techAI agentdata vault

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellbyte Comparables

Compare Cellbyte with similar companies based on industry and business-model similarity.

Cellbyte comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cohere
89%
TRiBECA Knowledge
78%
Sleuth Insights
76%

Cellbyte Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 18, 2025
AcceleratorApr 3, 2024

Key People

Founding team and executive leadership

Samuel M.

Co-founder & CTO

Founding Team

Daniel Moreira

Co-founder & Co-CEO

Founding Team

Cellbyte Investors

Notable investors and investment history

Cellbyte investors
InvestorRounds
Saras CapitalSeed
Pace VenturesSeed
Y CombinatorAccelerator, Seed
Springboard Health AngelsSeed
Frontline VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 110% MoM, reaching 1.2K.

  • Feb 10, 2026

    Grew 100% QoQ, from 5 to 10 employees.

Cellbyte Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellbyte Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellbyte's valuation, stock price, and market status.

Firmographic Details

HeadquartersMunich
Employee Range11
Year Founded2024
Last FundingNov 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?